FULC
Beyond's analysis on FULC
Recent news mentioning FULC
- — Are UTZ, ITGR, FULC Obtaining Fair Deals for their Shareholders?
- — Fulcrum and Woolpert Connect Utility Vegetation Risk Data Straight to the Crews Who Act on It
- — Are UTZ, VCTR, FULC, CZR Obtaining Fair Deals for their Shareholders?
- — Fulcrum (FULC) is Allocating 95% of the Combined Company to Slate and PIPE Investors. Is the $270M Dividend Enough?
- — Are WEAV, FULC, BRBS Obtaining Fair Deals for their Shareholders?
- — $HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - HOWL, HZO, TYFG and FULC
- — Fulcrum and Slate Medicines sign merger agreement
- — Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?
- — Shareholder Alert: Ademi LLP investigates whether Fulcrum Therapeutics, Inc. is obtaining a Fair Price for Public Shareholders
- — Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies
- — Fulcrum Therapeutics Merges With Slate in $245M Migraine Biotech Deal
- — Slate, Fulcrum to combine in reverse merger
Appears alongside
Browse the full archive →